Insights

Expert articles, thought leadership, AI in cardiology.

NT-proBNP and Diabetes: Risks of Misdiagnosis in Heart Failure

NT-proBNP and diabetes — heart illustration, blood vials, and a laptop displaying a Cardio-HART report, illustrating heart-failure diagnosis in diabetic patients

NT-proBNP and diabetes are closely linked, and this interplay can alter test interpretation in heart-failure diagnosis. N-terminal pro B-type natriuretic peptide (NT-proBNP) is a biomarker widely used to assess heart failure (HF) and other cardiovascular conditions. It is the inactive fragment released when the heart produces brain natriuretic peptide (BNP), a hormone involved in fluid […]

NT-proBNP and Diabetes: Risks of Misdiagnosis in Heart Failure Read More »

NT-proBNP in Heart Failure Diagnosis: Clinical Delay, Biomarker Limits, and the Need for Diagnostic Reinvention

  Misconceptions, Misuse, and Missed Diagnoses in the Primary Care Pathway. Abstract – Misuse of NT-proBNP in Primary Care and Diagnostic Delays N-terminal pro B-type natriuretic peptide (NT-proBNP) is widely used in the diagnostic pathway for heart failure (HF). While it remains a sensitive marker for excluding HF, particularly in acute settings, its application in

NT-proBNP in Heart Failure Diagnosis: Clinical Delay, Biomarker Limits, and the Need for Diagnostic Reinvention Read More »

NT-proBNP in Heart Failure Diagnosis: Challenges, Clinical Effectiveness, and the Need for More Accurate Tools

Abstract N-terminal pro B-type natriuretic peptide (NT-proBNP) has long been used as a biomarker for diagnosing heart failure (HF), especially in emergency settings. However, its clinical effectiveness in diagnosing heart failure with preserved ejection fraction (HFpEF), particularly in older adults, remains a subject of debate due to high false-positive (FP) rates and evolving diagnostic criteria.

NT-proBNP in Heart Failure Diagnosis: Challenges, Clinical Effectiveness, and the Need for More Accurate Tools Read More »

Cardio-HART and QTc

CHART and QTc Introduction The Cardio-HART (CHART) system assesses the QT interval as part of a comprehensive 12-lead ECG interpretation. CHART is specifically designed to provide a detailed evaluation of QT interval severity. This includes distinguishing between borderline cases and cases with prolonged or shortened QTc, with additional support provided through multiple QTc measurements. The

Cardio-HART and QTc Read More »

Prevention in Cardiology: The Power of Community Support with Cardio-HART

Preventive care is crucial in the field of cardiology. Recognizing the importance of early detection and proactive care, Cardio Phoenix has developed Cardio-HART—a groundbreaking solution for the early detection of cardiovascular diseases. As Cardio Phoenix applies for NIHR i4i funding to further its research, it becomes increasingly crucial to emphasize the significance of community support

Prevention in Cardiology: The Power of Community Support with Cardio-HART Read More »

Telemedicine for the heart post COVID-19 / Sportello Cuore – Italy

The research develops systems that bring general practitioners and specialists together to identify and monitor those at risk. The great challenge to SARS-CoV-2 virus infection is played out on the ground, through the early identification of new infections and the identification of those at greater risk, such as people with confirmed cardiovascular diseases or risk

Telemedicine for the heart post COVID-19 / Sportello Cuore – Italy Read More »